ArticleCancer immunology, immunotherapy : CII2024
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.
Carlo Messina et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.